Nihon Kohden (OTCMKTS:NHNKY) Hits New 1-Year Low – What’s Next?

Nihon Kohden Corporation (OTCMKTS:NHNKYGet Free Report) shares reached a new 52-week low on Tuesday . The stock traded as low as $8.70 and last traded at $8.70, with a volume of 4499 shares traded. The stock had previously closed at $8.76.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded Nihon Kohden to a “hold” rating in a research report on Monday, April 27th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Buy”.

Read Our Latest Research Report on NHNKY

Nihon Kohden Trading Up 1.8%

The company has a 50 day simple moving average of $9.30 and a 200-day simple moving average of $10.20. The stock has a market cap of $1.49 billion, a price-to-earnings ratio of 14.78 and a beta of 0.39.

Nihon Kohden (OTCMKTS:NHNKYGet Free Report) last released its quarterly earnings results on Thursday, May 14th. The company reported $0.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.10. Nihon Kohden had a return on equity of 9.48% and a net margin of 6.08%.The firm had revenue of $453.10 million for the quarter, compared to the consensus estimate of $414.40 million. Equities analysts forecast that Nihon Kohden Corporation will post 0.61 earnings per share for the current fiscal year.

About Nihon Kohden

(Get Free Report)

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.

See Also

Receive News & Ratings for Nihon Kohden Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nihon Kohden and related companies with MarketBeat.com's FREE daily email newsletter.